D. German

Parkinson’s Disease Blood Test for Primary Care
20220 citationsauthor #5
Targeted Metabolomic Analysis in Alzheimer’s Disease Plasma and Brain Tissue in Non-Hispanic Whites
202238 citationsauthor #2
Mapping reward mechanisms by intracerebral self‐stimulation in the rhesus monkey (Macaca mulatta)
20213 citationsauthor #2
Author response for "Mapping Reward Mechanisms by Intracerebral Self Stimulation in the Rhesus Monkey (Macaca mulatta)"
20210 citationsauthor #2
Blood biomarker discovery for autism spectrum disorder: A proteomic analysis
202154 citationsauthor #6
Decision letter for "Expression profiling of precuneus layer III cathepsin D‐immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability"
20191 citationsauthor #1
Finding useful biomarkers for Parkinson’s disease
2018128 citationsauthor #15
Antibody biomarker for de novo Parkinson disease: attempted validation
201810 citationsauthor #6
Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.
201759 citationsauthor #14
Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder
20170 citationsauthor #10
Serum thyroid-stimulating hormone and interleukin-8 levels in boys with autism spectrum disorder
201734 citationsauthor #10
Blood biomarker for Parkinson disease: peptoids
201621 citationsauthor #7
A Search for Blood Biomarkers for Autism: Peptoids
201628 citationsauthor #13
The NINDS Parkinson's disease biomarkers program
2016102 citationsauthor #9
Serum Antibody Biomarkers for ASD
20150 citationsauthor #1
Erratum: Administration of thimerosal-containing vaccines to infant rhesus macaques does not result in autism-like behavior or neuropathology (Proceedings of the National Academy of Sciences of the United States of America (2015) 112: (12498-12503) DOI: 10.1073/pnas.1500968112)
20151 citationsauthor #16
Klotho Protects Dopaminergic Neuron Oxidant-Induced Degeneration by Modulating ASK1 and p38 MAPK Signaling Pathways
201557 citationsauthor #2
Does administration of thimerosal-containing vaccines to infant rhesus macaques result in an autism-like neuropathology?
20151 citationsauthor #9
Administration of thimerosal-containing vaccines to infant rhesus macaques does not result in autism-like behavior or neuropathology
201532 citationsauthor #17
P1‐131: ALZHEIMER'S DISEASE AND PARKINSON's DISEASE: BLOOD BIOMARKER DIFFERENCES
20140 citationsauthor #1
Beta-amyloid auto-antibodies are reduced in Alzheimer's disease.
201449 citationsauthor #5
Elevated serum DDE and risk for Alzheimer disease--reply.
20141 citationsauthor #3
Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates.
201416 citationsauthor #6
Validation of a Serum Screen for Alzheimer's Disease Across Assay Platforms, Species, and Tissues
201483 citationsauthor #5
Alzheimer disease risk factors.
20145 citationsauthor #2
Elevated serum pesticide levels and risk for Alzheimer disease.
2014227 citationsauthor #9
P1–232: Validation of a serum‐based screen for Alzheimer's disease
20130 citationsauthor #2
Neuropathology and Animal Models of Autism: Genetic and Environmental Factors
201367 citationsauthor #4
Parkinson's Disease: A Role for the Immune System.
201313 citationsauthor #1
The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.
201374 citationsauthor #8
Nuclear localization of Klotho in brain: an anti-aging protein.
201289 citationsauthor #1
Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease.
201285 citationsauthor #8
Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation
201270 citationsauthor #8
1.130 INVERSE RELATIONSHIP BETWEEN THE CONTENTS OF NEUROMELANIN PIGMENT AND THE VESICULAR MONOAMINE TRANSPORTER-2 AMONG SUBSTANTIA NIGRA AND VENTERAL TEGMENTAL AREA
20120 citationsauthor #2
P3‐128: A DDT metabolite is elevated in the serum of Alzheimer's disease patients
20120 citationsauthor #1
P-073: Elevated Serum Levels of p,pʼ-DDE are Associated with Increased Risk for Alzheimerʼs Disease
20120 citationsauthor #8
antidepressant influences on thalamic volume Major depression, 5HTTLPR genotype, suicide and
20110 citationsauthor #5
β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease.
201150 citationsauthor #10
P1‐085: Serum antibody biomarkers for Alzheimer's disease
20110 citationsauthor #1
Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening.
2011195 citationsauthor #7
Elevated serum pesticide levels and risk of Parkinson disease.
2009136 citationsauthor #8
A stereotactic near-infrared probe for localization during functional neurosurgical procedures: further experience.
200947 citationsauthor #3
Acute and Chronic Administration of 1-Methyl-4-Phenylpyridinium
20081 citationsauthor #3
Further Experience with a Stereotactic Near-infrared Probe for Localization during Functional Neurosurgical Procedures: 863
20080 citationsauthor #3
Major depression, 5HTTLPR genotype, suicide and antidepressant influences on thalamic volume
200876 citationsauthor #5
Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson's disease.
200828 citationsauthor #3
5HTTLPR polymorphism and enlargement of the pulvinar: unlocking the backdoor to the limbic system.
200787 citationsauthor #6
Mouse models of alzheimer's disease
200718 citationsauthor #1
A Robust Biomarker Discovery Pipeline for High-Performance Mass Spectrometry Data
20079 citationsauthor #9
Serum biomarkers for Alzheimer's disease: proteomic discovery.
200766 citationsauthor #1
Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.
2007187 citationsauthor #4
Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease
2006369 citationsauthor #5
Determination of reduced scattering coefficient of biological tissue from a needle-like probe.
2005122 citationsauthor #3
The PDAPP mouse model of Alzheimer's disease: Locus coeruleus neuronal shrinkage
200551 citationsauthor #1
Molecular, anatomical, and biochemical events associated with neurodegeneration in mice with Niemann-Pick type C disease.
2005119 citationsauthor #6
Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter‐2: Human midbrain dopamine neurons
2004115 citationsauthor #5
Elevated neuron number in the limbic thalamus in major depression.
2004166 citationsauthor #5
INTERACTION OF VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) AND NEUROMELANIN PIGMENT AMONG THE MIDBRAIN DOPAMINERGIC NEURONS, IN MAN
20040 citationsauthor #2
Mouse Models of Alzheimer's Disease: Insight into Treatment
2004117 citationsauthor #1
Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.
2004407 citationsauthor #9
499 Insight into the cause and treatment of Alzheimer's disease from a transransgenic mouse model
20030 citationsauthor #3
Cholinergic neuropathology in a mouse model of Alzheimer's disease
2003100 citationsauthor #1
Validation of a near-infrared probe for detection of thin intracranial white matter structures.
200348 citationsauthor #6
Neurodegeneration in the Niemann-Pick C mouse: glial involvement.
2002170 citationsauthor #1
OF PRIMATE LOCUS COERULEUS AND SUBCOERULEUS NEURONS TO STIMULATION AT REINFORCING BRAIN SITES AND TO NATURAL REINFORCERS
200218 citationsauthor #1
A Role for the Vesicular Monoamine Transporter (VMAT2) in Parkinson’s Disease
20025 citationsauthor #1
Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann‐Pick C disease
2001122 citationsauthor #1
Upregulation of estrogen receptors in the forebrain of aromatase knockout (ArKO) mice.
200044 citationsauthor #5
Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia.
2000279 citationsauthor #5
Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells.
199893 citationsauthor #6
Calbindin-D28k in nerve cell nuclei.
199751 citationsauthor #1
Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP
199750 citationsauthor #5
The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
1996143 citationsauthor #1
Calbindin buffering of intracellular calcium increases in pc12 cells
19960 citationsauthor #5
Calbindin-D28K in the nucleus of nerve growth factor-treated PC12 cells.
19965 citationsauthor #6
The neurotoxin MPTP increases calbindin-D28k levels in mouse midbrain dopaminergic neurons.
199630 citationsauthor #8
Midbrain dopaminergic neurons in the mouse: Computer‐assisted mapping
1996142 citationsauthor #4
Locus coeruleus cell loss in the aging human brain: A non‐random process
1995200 citationsauthor #4
Calbindin-D28k-containing neurons in the human hypothalamus: relationship to dopaminergic neurons.
199513 citationsauthor #3
Low dopamine transporter mRNA levels in midbrain regions containing calbindin.
199439 citationsauthor #6
Neuroactive peptides exist in the midbrain dopaminergic neurons that contain calbindin-D28k.
199317 citationsauthor #1
Midbrain dopaminergic neurons (nuclei A8, A9, and A10): Three‐dimensional reconstruction in the rat
1993261 citationsauthor #1
Leucine5‐enkephalin afferents to midbrain dopaminergic neurons: Light and electron microscopic examination
199315 citationsauthor #3
Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity.
1992197 citationsauthor #3
Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cells a
1992327 citationsauthor #1
Disease‐specific patterns of locus coeruleus cell loss
1992512 citationsauthor #1
ACTH1-39 inputs to mesocorticolimbic dopaminergic neurons: light and electron microscopic examination.
199210 citationsauthor #4
Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease
199195 citationsauthor #3
Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse
199114 citationsauthor #4
Increased midbrain dopaminergic cell activity following 2'CH3-MPTP-induced dopaminergic cell loss: an in vitro electrophysiological study.
199019 citationsauthor #3
Extensive survival of chromaffin cells in adrenal medulla "ribbon" grafts in the monkey neostriatum.
199023 citationsauthor #2
Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization
1989417 citationsauthor #1
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies.
198915 citationsauthor #7
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
1988204 citationsauthor #1
Transplant improves hemiparkinsonian syndrome in nonhuman primate: intracerebral injection, rotometry, tyrosine hydroxylase immunohistochemistry.
198828 citationsauthor #4
Anatomical and electrophysiological characterization of presumed dopamine-containing neurons within the supramammillary region of the rat.
198823 citationsauthor #3
Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex
1987200 citationsauthor #1
Primate neostriatal neurons containing tyrosine hydroxylase: immunohistochemical evidence.
1987164 citationsauthor #6
Hypothalamic pathology in Alzheimer's disease.
1987151 citationsauthor #3
Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease.
1987232 citationsauthor #3

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT